Fannin Innovation Studio
Dr. Atul Varadhachary is Managing Partner at Fannin Innovation Studio which works with innovators at the institutions in the Texas Medical Center in Houston to help commercialize early-stage technologies in the life sciences. Fannin partners with innovators to co-found companies that it actively manages in addition to putting in seed capital and providing space and back-office support. Atul also serves as an Adjunct Professor at Rice University’s Jones School of Business, the Baylor College of Medicine and the University Texas School of Public Health.
Before Fannin, Atul served as President of U.S. Operations at Reliance Life Sciences, part of the Reliance Group, India’s largest private sector enterprise with over $75 billion in annual revenues. Atul served for nine years as President & COO of Agennix, Inc., a late-stage biotechnology company where he led advancement of Agennix’s lead molecule from preclinical studies into pivotal Phase 3 human studies and helped lead a successful sale of the company.
Before joining Agennix in 2001, Atul was a Senior Engagement Manager in the Houston office of McKinsey & Co., serving in their Houston office since 1994. He co-founded and ran Pratham Health (now the Niramaya Health Foundation), a preventive health program reaching 65,000 poor pre-school children in India, while on a leave of absence from McKinsey. Atul was a founding director of Pratham USA, and has served as the President of Pratham USA. He currently serves on the Pratham Education Foundation, the ASER and the Niramaya Boards.
Atul has also served on the Board of Managers of the Harris Health System and chaired its strategic planning committee. Harris Health runs two full-service hospitals (Ben Taub and Lyndon B. Johnson) and thirty clinics and other ambulatory centers. Harris Health also serves as a teaching system for Baylor College of Medicine and University of Texas Health Sciences Center at Houston.
Atul serves or has served on multiple other community boards including those of the Center For Public Policy Priorities (CPPP), TiE Houston, and the Indo-American Chamber of Commerce of Greater Houston (IACCGH) where he served as President in 2008-09. He also serves on the Healthcare Advisory Committee of the Greater Houston Partnership on the Jones Health Care Advisory Board, and the Life Sciences Advisory Committee of the Houston Technology Center.
Company boards on which Atul serves include Acelerox, ACF Pharma, Atrapos Therapeutics, Avid Chemotherapeutics, BreviTest, Bystander Therapeutics, Exotect, GuidaBot, and Pulmotect.